BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bhushan A, Singh A, Kapur S, Borthakar BB, Sharma J, Rai AK, Kataki AC, Saxena S. Identification and Validation of Fibroblast Growth Factor 12 Gene as a Novel Potential Biomarker in Esophageal Cancer Using Cancer Genomic Datasets. OMICS 2017;21:616-31. [PMID: 29049013 DOI: 10.1089/omi.2017.0116] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gao X, Liao Z, Su R, Zheng D, Huang G, Huang Z, Cheng X, Liao Z. Depletion of Fibroblast Growth Factor 12 Restrains the Viability, Stemness, and Motility of Colorectal Cancer. BioMed Research International 2022;2022:1-11. [DOI: 10.1155/2022/9948461] [Reference Citation Analysis]
2 Li M, Wu S, Luo H, Niu J, Yan Y, Fang Y, Ke L, Chen W, Xu H, Li H, Hu X, Cao L, Chen Y, Tu H, He Y. Serological and Molecular Characterization of Hepatitis B Virus Infection in Gastric Cancer. Front Cell Infect Microbiol 2022;12:894836. [DOI: 10.3389/fcimb.2022.894836] [Reference Citation Analysis]
3 Si J, Ding X, Deng Z, Li P, Zhang B, Lan G, Huang B, Liang J, Wang Z, Si Y. A Four-Gene Signature Model Improves the Prediction of Distant Metastasis in Patients with Nasopharyngeal Carcinoma: A Retrospective, Three-Center Observational Study. Technol Cancer Res Treat 2022;21:15330338221080972. [PMID: 35262435 DOI: 10.1177/15330338221080972] [Reference Citation Analysis]
4 Bhushan A, Kumari R, Srivastava T. Scouting for common genes in the heterogenous hypoxic tumor microenvironment and their validation in glioblastoma. 3 Biotech 2021;11:451. [PMID: 34631352 DOI: 10.1007/s13205-021-02987-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Demircan T, Yavuz M, Akgül S. m6A Pathway Regulators Are Frequently Mutated in Breast Invasive Carcinoma and May Play an Important Role in Disease Pathogenesis. OMICS 2021;25:660-78. [PMID: 34520276 DOI: 10.1089/omi.2021.0114] [Reference Citation Analysis]
6 Wang L, Han H, Wang Z, Shi L, Yang M, Qin Y. Targeting the Microenvironment in Esophageal Cancer. Front Cell Dev Biol 2021;9:684966. [PMID: 34513829 DOI: 10.3389/fcell.2021.684966] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Feng P, Li H, Pei J, Huang Y, Li G. Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL). Front Genet 2021;12:625414. [PMID: 33643388 DOI: 10.3389/fgene.2021.625414] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Dagamajalu S, Vijayakumar M, Shetty R, Rex DAB, Narayana Kotimoole C, Prasad TSK. Proteogenomic examination of esophageal squamous cell carcinoma (ESCC): new lines of inquiry. Expert Rev Proteomics 2020;17:649-62. [PMID: 33151123 DOI: 10.1080/14789450.2020.1845146] [Reference Citation Analysis]
9 Xie Y, Su N, Yang J, Tan Q, Huang S, Jin M, Ni Z, Zhang B, Zhang D, Luo F, Chen H, Sun X, Feng JQ, Qi H, Chen L. FGF/FGFR signaling in health and disease. Signal Transduct Target Ther 2020;5:181. [PMID: 32879300 DOI: 10.1038/s41392-020-00222-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 109] [Article Influence: 16.5] [Reference Citation Analysis]